Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 29, 2017 - Issue 3
343
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Modeling vascular inflammation and atherogenicity after inhalation of ambient levels of ozone: exploratory lessons from transcriptomics

, , , , &
Pages 96-105 | Received 04 Dec 2016, Accepted 17 Mar 2017, Published online: 16 Apr 2017

References

  • Arjomandi M, Witten A, Abbritti E et al. (2005). Repeated exposure to ozone increases alveolar macrophage recruitment into asthmatic airways. Am J Respir Crit Care Med 172:427–32.
  • Arjomandi M, Wong H, Donde A et al. (2015). Exposure to medium and high ambient levels of ozone causes adverse systemic inflammatory and cardiac autonomic effects. Am J Physiol Heart Circ Physiol 308:H1499–509.
  • Balmes JR, Aris RM, Chen LL, et al. (1997). Effects of ozone on normal and potentially sensitive human subjects. Part I: airway inflammation and responsiveness to ozone in normal and asthmatic subjects. Res Rep Health Eff Inst 1–37. Discussion 81–99.
  • Bell ML, McDermott A, Zeger SL et al. (2004). Ozone and short-term mortality in 95 US urban communities, 1987–2000. JAMA 292:2372–8.
  • Brook RD, Brook JR, Urch B et al. (2002). Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults. Circulation 105:1534–6.
  • Brook RD, Rajagopalan S, Pope CA 3rd et al. (2010). Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation 121:2331–78.
  • Castleman WL, Dungworth DL, Schwartz LW, Tyler WS. (1980). Acute respiratory bronchiolitis: an ultrastructural and autoradiographic study of epithelial cell injury and renewal in rhesus monkeys exposed to ozone. Am J Pathol 98:811–40.
  • Chen C, Arjomandi M, Balmes J et al. (2007). Effects of chronic and acute ozone exposure on lipid peroxidation and antioxidant capacity in healthy young adults. Environ Health Perspect 115:1732–7.
  • Chen C, Arjomandi M, Qin H et al. (2006). Cytogenetic damage in buccal epithelia and peripheral lymphocytes of young healthy individuals exposed to ozone. Mutagenesis 21:131–7.
  • Chen Q, Jin M, Yang F et al. (2013). Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediators Inflamm 2013:928315.
  • Chuang GC, Yang Z, Westbrook DG et al. (2009). Pulmonary ozone exposure induces vascular dysfunction, mitochondrial damage, and atherogenesis. Am J Physiol Lung Cell Mol Physiol 297:L209–16.
  • Devlin RB, Duncan KE, Jardim M et al. (2012). Controlled exposure of healthy young volunteers to ozone causes cardiovascular effects. Circulation 126:104–11.
  • Dickhout JG, Basseri S, Austin RC. (2008). Macrophage function and its impact on atherosclerotic lesion composition, progression, and stability: the good, the bad, and the ugly. Arterioscler Thromb Vasc Biol United States 28:1413–15.
  • Donaldson K, Stone V, Seaton A, MacNee W. (2001). Ambient particle inhalation and the cardiovascular system: potential mechanisms. Environ Health Perspect 109(Suppl 4):523–7.
  • Farraj AK, Hazari MS, Winsett DW et al. (2012). Overt and latent cardiac effects of ozone inhalation in rats: evidence for autonomic modulation and increased myocardial vulnerability. Environ Health Perspect 120:348–54.
  • Glurich I, Grossi S, Albini B et al. (2002). Systemic inflammation in cardiovascular and periodontal disease: comparative study. Clin Diagn Lab Immunol 9:425–32.
  • Go AS, Mozaffarian D, Roger VL et al. (2014). Heart disease and stroke statistics – 2014 update: a report from the American Heart Association. Circulation 129:e28–292.
  • Gui T, Shimokado A, Sun Y et al. (2012). Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery. Mediators Inflamm 2012:693083.
  • Heo DS, Heo DS, Choi H et al. (2014). Serum levels of matrix metalloproteinase-9 predict lymph node metastasis in breast cancer patients. Oncol Rep 31:1567–72.
  • Hiraiwa K, van Eeden SF. (2013). Contribution of lung macrophages to the inflammatory responses induced by exposure to air pollutants. Mediators Inflamm 2013:619523.
  • Inoue T, Matsuoka H, Higashi Y et al. (2008). Flow-mediated vasodilation as a diagnostic modality for vascular failure. Hypertens Res 31:2105–13.
  • Jerrett M, Burnett RT, Pope CA 3rd et al. (2009). Long-term ozone exposure and mortality. N Engl J Med 360:1085–95.
  • Kao YH, Mohler ER, Arger PH, Sehgal CM. (2003). Brachial artery: measurement of flow-mediated dilatation with cross-sectional US – technical validation. Radiology 228:895–900.
  • Khokha R, Murthy A, Weiss A. (2013). Metalloproteinases and their natural inhibitors in inflammation and immunity. Nat Rev Immunol 13:649–65.
  • Kodavanti UP, Thomas R, Ledbetter AD et al. (2011). Vascular and cardiac impairments in rats inhaling ozone and diesel exhaust particles. Environ Health Perspect 119:312–18.
  • Koren HS, Devlin RB, Graham DE et al. (1989). Ozone-induced inflammation in the lower airways of human subjects. Am Rev Respir Dis 139:407–15.
  • Kumarathasan P, Blais E, Saravanamuthu A et al. (2015). Nitrative stress, oxidative stress and plasma endothelin levels after inhalation of particulate matter and ozone. Part Fibre Toxicol 12:28.
  • Kupershmidt I, Su QJ, Grewal A et al. (2010). Ontology-based meta-analysis of global collections of high-throughput public data. PLoS One 5: e13066
  • Leikauf GD, Simpson LG, Santrock J et al. (1995). Airway epithelial cell responses to ozone injury. Environ Health Perspect 103(Suppl 2):91–5.
  • Leroy P, Tham A, Wong H et al. (2015). Inflammatory and repair pathways induced in human bronchoalveolar lavage cells with ozone inhalation. PLoS One 10:e0127283.
  • Li Y, Rittenhouse-Olson K, W LS, Mu L. (2012). Effect of particulate matter air pollution on C-reactive protein: a review of epidemiologic studies. Rev Environ Health 27:133–49.
  • Libby P, Ridker PM, Hansson GK. (2011). Progress and challenges in translating the biology of atherosclerosis. Nature 473:317–25.
  • Liberale L, Dallegri F, Montecucco F, Carbone F. (2016). Pathophysiological relevance of macrophage subsets in atherogenesis. Thromb Haemost 117:593.
  • Liu P, Sun M, Sader S. (2006). Matrix metalloproteinases in cardiovascular disease. Can J Cardiol 22(Suppl B):25B–30B.
  • Lund AK, Knuckles TL, Obot Akata C et al. (2007). Gasoline exhaust emissions induce vascular remodeling pathways involved in atherosclerosis. Toxicol Sci 95:485–94.
  • Lund AK, Lucero J, Lucas S et al. (2009). Vehicular emissions induce vascular MMP-9 expression and activity associated with endothelin-1-mediated pathways. Arterioscler Thromb Vasc Biol 29:511–7.
  • Michaudel C, Couturier-Maillard A, Chenuet P et al. (2016). Inflammasome, IL-1 and inflammation in ozone-induced lung injury. Am J Clin Exp Immunol 5:33–40.
  • Moore K, Sheedy F, Fisher E. (2013). Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol 13:709–21.
  • Moore KJ, Tabas I. (2011). The cellular biology of macrophages in atherosclerosis. Cell 145:341–55.
  • Paffett ML, Zychowski KE, Sheppard L et al. (2015). Ozone inhalation impairs coronary artery dilation via intracellular oxidative stress: evidence for serum-borne factors as drivers of systemic toxicity. Toxicol Sci 146:244–53.
  • Page-McCaw A, Ewald AJ, Werb Z. (2007). Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8:221–33.
  • Pant S, Deshmukh A, Gurumurthy GS et al. (2014). Inflammation and atherosclerosis-revisited. J Cardiovasc Pharmacol Ther 19:170–8.
  • Pino MV, Levin JR, Stovall MY, Hyde DM. (1992). Pulmonary inflammation and epithelial injury in response to acute ozone exposure in the rat. Toxicol Appl Pharmacol 112:64–72.
  • Pryor WA, Squadrito GL, Friedman M. (1995). A new mechanism for the toxicity of ozone. Toxicol Lett 82–83:287–93.
  • Robertson S, Colombo ES, Lucas SN et al. (2013). CD36 mediates endothelial dysfunction downstream of circulating factors induced by O3 exposure. Toxicol Sci 134:304–11.
  • Ruidavets JB, Cournot M, Cassadou S et al. (2005). Ozone air pollution is associated with acute myocardial infarction. Circulation 111:563–9.
  • Shi L, Tong W, Fang H et al. (2005). Cross-platform comparability of microarray technology: intra-platform consistency and appropriate data analysis procedures are essential. BMC Bioinformatics 6(Suppl 2):S12.
  • Suissa L, Fortier M, Lachaud S et al. (2013). Ozone air pollution and ischaemic stroke occurrence: a case-crossover study in Nice, France. BMJ Open 3:e004060.
  • Suwa T, Hogg JC, Quinlan KB et al. (2002). Particulate air pollution induces progression of atherosclerosis. J Am Coll Cardiol 39:935–42.
  • Taleb S. (2016). Inflammation in atherosclerosis. Arch Cardiovasc Dis. 109:708–15
  • Turner MC, Jerrett M, Pope CA III et al. (2016). Long-term ozone exposure and mortality in a large prospective study. Am J Respir Crit Care Med 193:1134–42. Available from http://www.ncbi.nlm.nih.gov/pubmed/26680605
  • Vacek TP, Rehman S, Neamtu D, et al. (2015). Matrix metalloproteinases in atherosclerosis: role of nitric oxide, hydrogen sulfide, homocysteine, and polymorphisms. Vasc Health Risk Manag 11:173–83.
  • Wagner JG, Allen K, Yang HY et al. (2014). Cardiovascular depression in rats exposed to inhaled particulate matter and ozone: effects of diet-induced metabolic syndrome. Environ Health Perspect 122:27–33.
  • Watanabe N, Ikeda U. (2004). Matrix metalloproteinases and atherosclerosis. Curr Atheroscler Rep 6:112–20.
  • Willerson JT. (2002). Systemic and local inflammation in patients with unstable atherosclerotic plaques. Prog Cardiovasc Dis 44:469–78.
  • Willerson JT, Ridker PM. (2004). Inflammation as a cardiovascular risk factor. Circulation 109:II2–10.
  • Zempo N, Koyama N, Kenagy RD et al. (1996). Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler Thromb Vasc Biol 16:28–33.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.